ERBB2 and breast cancer: In multivariate analysis, stage, age, M‐code, T‐code, N‐code, surgery, marital status, chemotherapy, liver, brain, and lung were identified as prognostic factors for patients with HER2‐positive HR‐negative breast cancer (Table 2).